Spectrum of Immune Checkpoint Inhibitors-Induced Endocrinopathies in Cancer Patients: A Scoping Review of Case Reports

Clinical Diabetes and Endocrinology - United Kingdom
doi 10.1186/s40842-018-0073-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Cardiotoxicity of Immune Checkpoint Inhibitors in Patients With Lung Cancer

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Neurotoxicities Associated With Checkpoint Inhibitors: Two Case Reports and a Review of the Literature

Clinical Case Reports
Medicine
2019English

Risk of Myocarditis in Patients With Cancer Treated With Immune Checkpoint Inhibitors

Chronicles of Oncology
2018English

Immune Checkpoint Inhibitors: A Step Forward in Cancer Management

Madridge Journal of Oncogenesis
2019English

Role of Immune Checkpoint Inhibitors in Gastrointestinal Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Risk of Hepatotoxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Published Data

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy